Puma Biotechnology Inc (NASDAQ: PBYI) Stock Information | RedChip

Puma Biotechnology Inc (NASDAQ: PBYI) Listen to this Section


$2.70
+0.0500 ( +1.89% ) 380.0K

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Market Data


Open


$2.70

Previous close


$2.65

Volume


380.0K

Market cap


$132.18M

Day range


$2.65 - $2.78

52 week range


$2.13 - $7.73

Insider Ownership Transactions

Total Amount Purchased: -249,000.00 | $ -672,300.00

Date Type Amount Purchased Purchaser
2024-06-21 Sale -27000.00 Dorval Allison
2024-06-21 Sale -27000.00 MILLER MICHAEL PATRICK
2024-06-21 Sale -27000.00 Senderowicz Adrian
2024-06-21 Sale -27000.00 Stuglik Brian M
2024-06-21 Sale -27000.00 MOYES JAY M
2024-06-21 Sale -27000.00 WILSON TROY EDWARD
2024-06-17 Sale -27000.00 Senderowicz Adrian
2024-06-17 Sale -22000.00 MOYES JAY M
2024-06-17 Sale -27000.00 WILSON TROY EDWARD
2024-06-17 Sale -11000.00 Dorval Allison

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 15 Jun 24, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.